‘Gene therapy for epilepsy: insights from seizure mechanisms’
Dimitri Kullmann studied medicine at Oxford and London Universities and completed a PhD in Oxford. Following postdoctoral research in the lab of Roger Nicoll at UCSF he established his laboratory at the Institute of Neurology, Queen Square London, and completed his neurology training at the National Hospital, Queen Square. He has worked on basic synaptic transmission and plasticity, neurological channelopathies, seizure mechanisms and gene therapy for epilepsy. He was the Editor-in-Chief of Brain between 2014 and 2020 and was made a Fellow of the Royal Society in 2018.
Dimitri Kullmann studied medicine at Oxford and London Universities and completed a PhD in Oxford. Following postdoctoral research in the lab of Roger Nicoll at UCSF he established his laboratory at the Institute of Neurology, Queen Square London, and completed his neurology training at the National Hospital, Queen Square. He has worked on basic synaptic transmission and plasticity, neurological channelopathies, seizure mechanisms and gene therapy for epilepsy. He was the Editor-in-Chief of Brain between 2014 and 2020 and was made a Fellow of the Royal Society in 2018.